PubMed Health⌕ Search

Biomedical subjects

P Brower

Publications and source records attributed to P Brower.

5 recordsLinked to original sources

Urinary tract abnormalities presenting as a result of blunt abdominal trauma.

Fourteen patients with unsuspected urinary tract abnormalities had their disorders diagnosed at the time of their evaluation for blunt abdominal trauma. The trauma was generally inconsequential but all of the patients had gross or microscopic hematuria. The diagnosis could be made by intravenous pyelography or physical examination in all of these patients, although in some patients the abnormality was not evident until the patient had an arteriogram. These disorders are usually detected in children, but 12 of our 14 patients were 19 years of age or older. The importance of the urogram for all patients with hematuria and minor abdominal trauma is emphasized by this group of patients.

Abdominal Injuries↗

Immunotherapy of cancer with "immune" RNA. A preliminary report.

A phase I clinical trial of immunotherapy with "Immune" RNA was undertaken fifteen months ago. Twenty-six cancer patients were treated with RNA extracted from the lymphoid organs of sheep immunized with either autologous tumor cells or allogeneic tumor cells of the same histologic type. Eighteen patients had gross disease and eight had minimum residual disease. RNA was administered weekly, intradermally, at doses up to 9 mg/week without any significant local or systemic toxicity. Four patients improved, thirteen achieved stability of disease or possible improvement, seven were treatment failures, and two are indeterminate. Lymphocyte-mediated cytotoxicity to allogeneic tumor target cells of the same histologic type were monitored in eleven patients. In seven patients, cytotoxicity increased after "Immune" RNA therapy; no change was observed in three patients; a decrease was noted in one patient. There appeared to be a possible correlation between cytotoxicity assessed in vitro and clinical response. There is some evidence that these responses may be specific for the particular tumor used to immunize the RNA donor.

Adenocarcinoma↗